Matthew Winton - 03 Apr 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
COO
Signature
/s/ Matthew Winton
Issuer symbol
INZY
Transactions as of
03 Apr 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 08:35:20 UTC
Next filing
15 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (right to buy) Award $0 +250,000 $0.000000 250,000 03 Apr 2023 Common Stock 250,000 $5.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 3, 2023 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date.